Clinical Trials Sponsored by Ottawa Allergy Research Corporation

Total 206 results

University of Zurich
Ottawa Allery Research Corporation

Terminated

Evaluation of a New Self-assessed, Home-based Symptom Score in Cat Allergic Patients (HypoScore-2)

Cat Allergy

Canada
Red Maple Trials Inc.
Ottawa Allergy Research Corporation

Completed

Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects (NEC)

Allergic Rhinitis | Rhinoconjunctivitis | Exposure

Canada
Ottawa Hospital Research Institute
Ottawa Heart Institute Research Corporation

Completed

Smoking Cessation With the Ottawa Model and SmartCard in Out-patient Respirology Clinic Setting (Quit&Win)

Smoking Cessation

Canada
Ottawa Hospital Research Institute
Ottawa Heart Institute Research Corporation

Completed

Cardiac MRI for Metal on Metal Hip Resurfacing (CardiacMRI)

Cardiomyopathy

Canada
Ottawa Heart Institute Research Corporation

Not yet recruiting

Exercise Testing Protocols for Females and Males With CAD (PACED)

Coronary Artery Disease
Ottawa Heart Institute Research Corporation

Not yet recruiting

Dapagliflozin in STEMI Randomized Clinical Trial (DAPA STEMI)

Myocardial Infarction | ST Elevation Myocardial Infarction

Canada
Ottawa Heart Institute Research Corporation

Not yet recruiting

Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users (VC-OMSC)

Tobacco Smoking | Vaping
Ottawa Heart Institute Research Corporation

Recruiting

Exercise Training in Women With Cardiac Devices (CIED-EX)

Cardiovascular Diseases

Canada
Ottawa Heart Institute Research Corporation

Recruiting

An Interactive Smartphone Application to Motivate Smokers to Quit (StepOne)

Smoking Cessation | Smoking Behaviors

Canada
Ottawa Heart Institute Research Corporation

Recruiting

CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock (DOREMI-2)

Shock, Cardiogenic

United States, Canada
Ottawa Heart Institute Research Corporation

Recruiting

QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT) (QOL-CAFRCT)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation (ACUTE-AF)

Atrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry (COVID-VIHPR)

Myocarditis | Pericarditis

Canada
Ottawa Heart Institute Research Corporation

Completed

Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias

Arrythmia

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

The COVID-RASi Trial (COVID-19)

Cardiovascular Diseases | COVID-19

Brazil, Canada, Mexico
Ottawa Heart Institute Research Corporation

Suspended

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND (RAPID EXTEND)

Myocardial Infarction | Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Enrolling by invitation

Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment (TRIGISTRY)

Tricuspid Regurgitation

United States, Spain, Israel, Canada, France, Germany, Netherlands, Switzerland, Austria, Italy
Ottawa Heart Institute Research Corporation

Completed

The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses (WALK)

Cardiovascular Diseases | Cardiovascular Risk Factor

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Feasibility of Transepicardial Atrial Injection

Cardiac Surgery

Canada
Ottawa Heart Institute Research Corporation

Completed

Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study

Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (CAPITAL PCI AF)

Atrial Fibrillation | Acute Coronary Syndrome

Canada
Ottawa Heart Institute Research Corporation

Completed

Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure

Heart Failure

Canada
Ottawa Heart Institute Research Corporation

Completed

Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation (PREHAB HTx Study) (PREHAB)

Heart Failure

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

Coronary Artery Disease | Diabetes Mellitus
Ottawa Heart Institute Research Corporation

Terminated

Optimization of SPECT Imaging (OSCARS)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Terminated

Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention (AVATAR)

Ventricular Tachycardia | Ventricular Arrhythmia

Canada
Ottawa Heart Institute Research Corporation

Completed

Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients

Stroke

Canada
Ottawa Heart Institute Research Corporation

Withdrawn

Cardiac Sarcoidosis Response To Steroids Trial (CASTOR)

Sarcoidosis | Cardiac Sarcoidosis

Canada
Ottawa Heart Institute Research Corporation

Completed

Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty

Platelet Reactivity

Canada
Ottawa Heart Institute Research Corporation

Not yet recruiting

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm (SEDATE)

Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Arrhythmias | Recurrent Ventricular Tachycardia
Ottawa Heart Institute Research Corporation

Recruiting

Florbetaben for Imaging of Vascular Amyloid (FERMATA)

Stroke | Transient Ischemic Attack | Acute Coronary Syndrome | Atherosclerosis of Artery

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study (HER-CROWN)

Cardiovascular Diseases

Canada
Ottawa Heart Institute Research Corporation

Not yet recruiting

Canagliflozin Targeting Vascular Inflammation (CANTORSING)

Coronary Artery Disease | Diabetes Type 2

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock (MINOS)

Mitral Regurgitation | Cardiogenic Shock

United States, Canada
Ottawa Heart Institute Research Corporation

Recruiting

Effect of Colchicine on the Progression of Aortic Valve Stenosis - A Pilot Study (COPAS-Pilot)

Inflammation | Aortic Stenosis

Canada
Ottawa Heart Institute Research Corporation

Recruiting

An Evaluation of the Talk Test for Exercise Prescription for Home-Based Cardiac Rehabilitation (Talk-Test)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial (CARA-VT RCT)

Ventricular Tachycardia

Canada
Ottawa Heart Institute Research Corporation

Recruiting

REvascularization and Valve Intervention for Ischemic Valve diseasE: REVIVE Trial (REVIVE)

Coronary Artery Disease | Mitral Valve Insufficiency

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation (Exercise-AF)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Peer Support for Women With Heart Disease: Women@Heart

Coronary Heart Disease | Women's Health

Canada
Ottawa Heart Institute Research Corporation

Recruiting

Comparing Hypothermic Temperatures During Hemiarch Surgery (TITAN:COMMENCE)

Thoracic Aortic Disease

United States, Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence (AWARE)

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

Prospective Treatment Algorithm Guiding Repair of Severe Ischemic Mitral Regurgitation

Mitral Regurgitation

Canada
Ottawa Heart Institute Research Corporation

Terminated

Cytisine Compared to Combination NRT in Relapsed Smokers (CYTvsNRT+)

Coronary Artery Disease | Smoking Cessation

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea. (AMEND)

Heart Failure | Obstructive Sleep Apnea | Central Sleep Apnea

Canada
Ottawa Heart Institute Research Corporation

Active, not recruiting

Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study (COAST-AF)

Persistent Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation

Terminated

Mobilization of Endothelial Progenitor Cells and Aspirin (TROPHIC 3)

Hypertrophic Obstructive Cardiomyopathy

Canada
Ottawa Heart Institute Research Corporation

Terminated

Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus

Coronary Artery Disease | Diabetes Mellitus

Canada
Ottawa Heart Institute Research Corporation

Completed

Smartphone Assessment Prior Radial Artery Harvesting for CABG (iRADIAL-CABG)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation

Completed

E-health Intervention for Cardiac Rehabilitation (VCRP-RCT)

Coronary Heart Disease | Valve Disease, Heart

Canada

Clinical Trials Sponsored by Ottawa Allergy Research Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations